Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome

Gene mutations have not yet been included in the 2016 WHO classification and revised International Prognostic Scoring System (IPSS-R), which are now widely utilized to discriminate myelodysplastic syndrome (MDS) patients regarding risk of leukemia evolution and overall survival (OS). In this study,...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood Cancer J
Главные авторы: Hou, Hsin-An, Tsai, Cheng-Hong, Lin, Chien-Chin, Chou, Wen-Chien, Kuo, Yuan-Yeh, Liu, Chieh-Yu, Tseng, Mei-Hsuan, Peng, Yen-Ling, Liu, Ming-Chih, Liu, Chia-Wen, Liao, Xiu-Wen, Lin, Liang-In, Yao, Ming, Tang, Jih-Luh, Tien, Hwei-Fang
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5884776/
https://ncbi.nlm.nih.gov/pubmed/29618722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0074-7
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы